Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 17/20 | 0.49 |
| ▸ | MPEG1 | Q2M385 | 11/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.49 |
| ▸ | XIAP | P98170 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | PTGES | O14684 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1535483 | 1.00 | ALOX5 (0.49) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL11086905 | 1.00 | ALOX5 (0.49) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL11081517 | 1.00 | ALOX5 (0.49) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL11080211 | 1.00 | ALOX5 (0.49) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL28192948 | 1.00 | ALOX5 (0.49) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL1535495 | 0.98 | ALOX5 (0.46) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL1535488 | 0.92 | ALOX5 (0.40) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL28925304 | 0.86 | ALDH1A1 (0.48) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL28642404 | 0.86 | ALDH1A1 (0.48) | ALOX5MPEG1GPR84XIAPALDH1A1 | |
| SCHEMBL27644549 | 0.86 | ALDH1A1 (0.48) | ALOX5MPEG1GPR84XIAPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4428959-A | 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | MERCK & CO., INC. (US) | 1984-01-31 | — | — | US | claimed |
| EP-0037991-B1 | 4-ALKYLSUBSTITUTED-3-HYDROXY-2-PYRROLINE-2,5-DIONE COMPOUNDS FOR USE IN THE PREVENTION AND TREATMENT OF KIDNEY AND BLADDER STONES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | MERCK & CO. INC. (US) | 1983-07-20 | — | — | EP | claimed |
| EP-0037991-A1 | 4-Alkylsubstituted-3-hydroxy-2-pyrroline-2,5-dione compounds for use in the prevention and treatment of kidney and bladder stones, process for preparing them and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1981-10-21 | — | — | EP | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-20180187233-A1 | SOLARGAS SYSTEM OPERATED IN MULTIPLE MODES | SOLAGA UG (DE) | 2018-07-05 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-4428959-A | 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | MERCK & CO., INC. (US) | 1984-01-31 | — | — | US | disclosed |
| EP-0037991-B1 | 4-ALKYLSUBSTITUTED-3-HYDROXY-2-PYRROLINE-2,5-DIONE COMPOUNDS FOR USE IN THE PREVENTION AND TREATMENT OF KIDNEY AND BLADDER STONES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | MERCK & CO. INC. (US) | 1983-07-20 | — | — | EP | disclosed |
| EP-0037991-A1 | 4-Alkylsubstituted-3-hydroxy-2-pyrroline-2,5-dione compounds for use in the prevention and treatment of kidney and bladder stones, process for preparing them and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1981-10-21 | — | — | EP | disclosed |